SAS Output

26-MAY-2017 18:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  2 1 52 2 24 2 12
BREAST 1238 39 2035 147 1790 273 1662
ERLYTX 152 13 678 35 426 54 329
GI 199 2 104 17 207 31 189
GU 673 7 365 40 487 91 554
LEUK 93 3 157 9 110 21 128
LUNG 340 8 417 42 511 78 475
LYMPH 17 0 0 0 0 1 6
MELAN 1016 29 1513 91 1108 208 1266
MMYEL 87 2 104 8 97 12 73
OTHER 32 1 52 4 49 5 30
Total 3849 105 5477 395 4809 776 4724

26-MAY-2017 18:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 11 0 0 2 24 4 24
Breast 3 1 52 1 12 1 6
CCD 1628 32 1670 124 1510 224 1364
GI 2 0 0 1 12 1 6
LEUK 3 0 0 0 0 1 6
LUNG 694 8 417 44 536 104 633
OTHER 12 2 104 4 49 6 37
PREV 60 0 0 6 73 15 91
SURV 54 1 52 5 61 12 73
SXQOL 58 0 0 1 12 1 6
Total 2525 44 2295 188 2289 369 2246

26-MAY-2017 18:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  2 1 52 2 24 2 12
BREAST 1249 39 2035 149 1814 277 1686
Breast 3 1 52 1 12 1 6
CCD 1628 32 1670 124 1510 224 1364
ERLYTX 152 13 678 35 426 54 329
GI 201 2 104 18 219 32 195
GU 673 7 365 40 487 91 554
LEUK 96 3 157 9 110 22 134
LUNG 1034 16 835 86 1047 182 1108
LYMPH 17 0 0 0 0 1 6
MELAN 1016 29 1513 91 1108 208 1266
MMYEL 87 2 104 8 97 12 73
OTHER 44 3 157 8 97 11 67
PREV 60 0 0 6 73 15 91
SURV 54 1 52 5 61 12 73
SXQOL 58 0 0 1 12 1 6
Total 6374 149 7774 583 7097 1145 6970

26-MAY-2017 18:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  2 1 52 2 24 2 12
BREAST 451 18 939 66 804 121 737
ERLYTX 132 10 522 25 304 40 244
GI 164 1 52 11 134 22 134
GU 445 6 313 25 304 63 384
LEUK 79 1 52 6 73 15 91
LUNG 215 5 261 29 353 56 341
LYMPH 17 0 0 0 0 1 6
MELAN 551 14 730 52 633 124 755
MMYEL 84 2 104 8 97 12 73
OTHER 32 1 52 4 49 5 30
Total 2172 59 3077 228 2775 461 2807

26-MAY-2017 18:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 11 0 0 2 24 4 24
Breast 2 0 0 0 0 0 0
CCD 1606 30 1565 117 1424 210 1278
GI 2 0 0 1 12 1 6
LEUK 3 0 0 0 0 1 6
LUNG 406 6 313 24 292 64 390
OTHER 11 1 52 3 37 5 30
PREV 44 0 0 5 61 12 73
SURV 35 1 52 5 61 10 61
SXQOL 58 0 0 1 12 1 6
Total 2178 38 1982 158 1923 308 1874

26-MAY-2017 18:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  2 1 52 2 24 2 12
BREAST 485 19 991 72 877 130 791
Breast 2 0 0 0 0 0 0
CCD 1606 30 1565 117 1424 210 1278
ERLYTX 132 10 522 25 304 40 244
GI 166 1 52 12 146 23 140
GU 450 6 313 25 304 63 384
LEUK 82 1 52 6 73 16 97
LUNG 623 11 574 53 645 120 731
LYMPH 17 0 0 0 0 1 6
MELAN 583 14 730 60 731 126 767
MMYEL 84 2 104 8 97 12 73
OTHER 67 2 104 7 85 12 73
PREV 44 0 0 5 61 12 73
SURV 35 1 52 5 61 10 61
SXQOL 58 0 0 1 12 1 6
Total 4436 98 5111 398 4844 778 4736

26-MAY-2017 18:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1108 33 1722 124 1510 238 1449
ERLYTX 53 10 522 25 304 38 231
GI 154 1 52 11 134 20 122
GU 587 7 365 36 438 84 511
LEUK 58 1 52 3 37 13 79
LUNG 310 8 417 38 463 68 414
MELAN 975 28 1461 82 998 195 1187
MMYEL 4 0 0 0 0 0 0
Total 3249 88 4591 319 3884 656 3993

26-MAY-2017 18:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1924 35 1826 162 1972 305 1857
AFFIL 176 0 0 11 134 25 152
CCOP/NCORP 2250 62 3235 213 2593 439 2672
Non-SWOG 2018 46 2400 191 2325 370 2252
Total 6368 143 7461 577 7024 1139 6933

26-MAY-2017 18:10

STUDIES CLOSED THIS MONTH

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LYMPH 9177 NHL, dose-adj. EPOCH+/-Rituximab 1 E 10-MAY-17
LYMPH C51101 CNS, myelo/non-myelo chemo, PhII 1 E 02-MAY-17

26-MAY-2017 18:10

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Registrations
CCD S1415CD TrACER CSF Standing Order Intervention for FN 1 28
MELAN S1404 Melan, Adv, HD-IFN/Ipilimumab vs MK-3475 2 23
MELAN S1404 Melan, Adv, HD-IFN/Ipilimumab vs MK-3475 1 20
BREAST S1007 Breast,Adj,N1,Endocrine+/-Chemo 1 19
ERLYTX EAY131 MATCH 0 12
LUNG S1400 SCCA,Adv, Biomarker Master 2 12
BREAST S1007 Breast,Adj,N1,Endocrine+/-Chemo 2 11
ERLYTX S1609 Rare Tumor, Comb Nivo/Ipi 1 10
BREAST S1207 Brst,Adj,Endocrine+/-Everolimus 1 9
LUNG S1400 SCCA,Adv, Biomarker Master 1 7
BREAST S1416 Brst, TNBC/BRCA, Cis+/- ABT-888 1 7
BREAST S1418 Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 2 6
MELAN S1320 Adv, BRAF mut, Inter v Contin 1 5
CCD S1417CD Colorectal, Cost Cohort Study 1 4
BREAST S1418 Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 4
LUNG S1507 NSCLC, Adv, Kras Mut, Trametinib + Docetaxel 1 4
ERLYTX EAY131 MATCH 1 3
GU S1314 Blad, COXEN Neoadj. Chemo + Cyst 1 3